ReviewIntegrative medicine research2015
Medicinal plants of the family Caryophyllaceae: a review of ethno-medicinal uses and pharmacological properties.
Review in Integrative medicine research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 146 citations in OpenAlex.
- GC-Ms, UHPLC-MS/MSChemistry & biodiversity · 2026Article
- Genetic diversity of Iranian Acanthophyllum species collection using SCoT and SRAP markers.Scientific reports · 2026Article
- Article
- Plastid phylogenomics illuminates backbone relationships, divergence times and character evolution in Caryophyllaceae.BMC plant biology · 2026Article
- Article
- De Novo Sequencing of Drymaria villosa and Comparative Analysis of Plastome in Caryophyllaceae Across 23 Species.Molecular biotechnology · 2025Article
- Phytochemical Profiling and Biological Evaluation ofPharmaceuticals (Basel, Switzerland) · 2025Article
- Unveiling the Potential of Three EndemicAntioxidants (Basel, Switzerland) · 2025Article
- Taxonomic clarification ofPhytoKeys · 2025Article
- Bolanthus turcicus: a promising antidiabetic with in-vitro antioxidant, enzyme inhibitory and antiadipogenic activities.Journal of molecular histology · 2024Article
- Phytochemical Profile and Antidiabetic, Antioxidant, and Anti-Inflammatory Activities ofAntioxidants (Basel, Switzerland) · 2024Article
- Standard medical ethnobotany of Kohistan, North Pakistan.Journal of ethnobiology and ethnomedicine · 2024Article
- Saponaria officinalis saponins as a factor increasing permeability of Candida yeasts' biomembrane.World journal of microbiology & biotechnology · 2024Article
- Overview of Ethnobotanical-Pharmacological Studies Carried Out on Medicinal Plants from the Serra da Estrela Natural Park: Focus on Their Antidiabetic Potential.Pharmaceutics · 2024Review
- Article
- Gypsogenin Battling for a Front Position in the Pentacyclic TriterpenesMolecules (Basel, Switzerland) · 2023Review
- New cyclic glycolipids fromRSC advances · 2023Article
- Wax Composition of SerbianPlants (Basel, Switzerland) · 2023Article
- Identification of the Plant Family Caryophyllaceae in Korea Using DNA Barcoding.Plants (Basel, Switzerland) · 2023Article
- Polyphenolic Profile ofPharmaceutics · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Several species of the family Caryophyllaceae are widely used by many ethnic communities as traditional medicine throughout the world. The highest number of plants of the family are used in Chinese traditional medicine. The ethnopharmacologial studies of this family indicate that plants of the family possess anticancer, antibacterial, antifungal, antiviral, antioxidant, and anti-inflammatory properties. Other miscellaneous properties reported are ribosome inactivation properties, inhibition of prostatic enlargement in rats, and inhibition of intestinal enzyme carboxyelasterase in rats, cerebro-protective activity, and antiobesity in rats. Few reviews have been published yet, providing information regarding medicinal plants of the family and their biomedical properties. All published reviews have focused either on a particular taxa or a few species. The present review is focused on the traditional medicinal uses of the plants of the family Caryophyllaceae along with phytochemical and pharmacological studies of the family. A study of the literature revealed significant traditional medicinal importance of the family. Major chemical constituents of Caryophyllceae are saponins, Phytoecdysteroids, benzenoids, phenyl propanoids, and nitrogen containing compounds. The most important property of plants of the family is anticancer activity and is shown by the large number of plant species studied. This review of traditional medicinal and pharmacological uses of plants of the family, provide a ground for future research in the family.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.